New Micro-extrusion Advanced Technology for plant-based whole-cut meat substitutes

NOVAMEAT uses tissue engineering and 3D printing to create sustainable, plant-based whole-cut meat alternatives with diverse nutritional and sensory profiles, addressing overpopulation and climate issues.

Subsidie
€ 1.860.725
2022

Projectdetails

Introduction

Due to the current overpopulation, climate change, and aggressive animal farming problems, there is an urgent need for the next generation of alternative proteins meat.

Technology Overview

Based on tissue engineering, food science, and 3D printing, NOVAMEAT has developed a micro-extrusion process that can bio-hack the native 3D network structure of molecules of plant origin. This process creates the microstructure and anisotropic morphology similar to that of traditional animal meat in a cost-efficient and highly scalable manner.

Unique Formulation

NOVAMEAT’s advanced and unique technology results in pieces of whole-cuts meat composed of a patent-pending formulation of:

  • A natural-origin wide range of different vegetable proteins
  • Fibres
  • Oils
  • Aromas

This formulation enables NewMEAT to achieve multiple varieties of nutritional, flavor, and texturization profiles similar to animal whole-cut meats.

Sustainability

NewMEAT does not contain soy but is composed of sustainable ingredients with much lower environmental impact. This approach supports resilient agriculture and animal welfare.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.860.725
Totale projectbegroting€ 2.658.178

Tijdlijn

Startdatum1-1-2022
Einddatum31-12-2023
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • NOVAMEAT TECH SLpenvoerder

Land(en)

Spain

Vergelijkbare projecten binnen EIC Accelerator

EIC Accelerator

Innovative patented dry fermentation technology for cost-effective and highly nutritious production of hybrid mycelium-plant meat analogues

The MEATLOW project aims to optimize a novel mycelium-plant fermentation technology to produce healthy, eco-friendly meat analogues for the EU market by 2026.

€ 2.441.250
EIC Accelerator

Using biotechnology to create the next generation of sustainable foods from the roots of mushrooms

Mushlabs uses proprietary fermentation technology to cultivate mycelium into a sustainable, protein-rich meat alternative, aiming to transform plant-based diets.

€ 2.426.375
EIC Accelerator

Harnessing the immense potential of precision fermentation to produce animal fats for the next generation of meat and dairy alternatives

Melt&Marble develops scalable, precision-fermentation technology to produce customizable, animal-like fats for plant-based foods, enhancing functionality and flavor while reducing environmental impact.

€ 2.485.840

Vergelijkbare projecten uit andere regelingen

Mkb-innovati...

Volwaardige Vegan Vleesvervangers

Rival Foods en FUL Foods ontwikkelen een nieuwe generatie vleesvervangers met verbeterde voedingswaarde en structuur, om de consumptie van vlees te verminderen en milieu-impact te verlagen.

€ 342.972
Mkb-innovati...

Productie van nieuwe vleesvervangers op basis van microbieel eiwit

Dalco Food en BioscienZ ontwikkelen een technologie voor de grootschalige productie van microbiële eiwitten uit groente- en fruitreststromen, gericht op efficiënte vleesvervangers en voedselveiligheid.

€ 113.663
Mkb-innovati...

CONTINUE TEXTURERING VAN PLANTAARDIGE EIWITTEN ALS RUNDVLEESANALOGA

Het project "CONTEXT" ontwikkelt een innovatieve technologie voor continue texturering van plantaardige eiwitten tot vleesanaloga, met als doel een breed scala aan vleesvervangers te produceren.

€ 348.180
Mkb-innovati...

Plant-Based Protein: Vleesvervangers o.b.v. veldbonen-eiwit

Het project richt zich op het ontwikkelen van een productieproces voor duurzame, lokaal geproduceerde plantaardige eiwitten om de consumptie van dierlijke eiwitten te verminderen.

€ 198.100
EIC Transition

A Revolutionary Tech for Exceptionally Efficient Natural Muscle Tissue Growth in Cultivated Meat Applications

ProFuse aims to optimize a novel myoblast cell line and media supplement to enhance the scalability and quality of cultivated meat, targeting TRL6 validation with potential clients.

€ 2.432.030